P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis

por Suhel, M.S., Chan, A., Nazareth, D., Wat, D., Walshaw, M.J., Green, D., Frost, F.
Publicado 2023